This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Alan R. Hinman, MD

Am J Dis Child. 1986;140(6):528-530.

Abstract
• Information provided by the three commercial manufacturers of diphtheria and tetanus toxoids and pertussis vaccine, adsorbed (DTP vaccine) indicates a striking increase in the number of lawsuits filed against them alleging damage caused by the vaccine. Only one such case was filed in 1978, whereas 73 were filed in 1984. During the seven-year period from 1978 to 1984, the average amount claimed per suit has risen from $10 million to $46.5 million. If the current trend continues, suits will pose an increasing threat to the availability of DTP vaccines in the United States.

(AJDC 1986;140:528-530)

Author Affiliations
From the Division of Immunization, Center for Prevention Services, Centers for Disease Control, Atlanta.

Footnotes
Accepted for publication Dec 26, 1985.

Reprint requests to Technical Information Services, Center for Prevention Services, Centers for Disease Control, Atlanta, GA 30333 (Dr Hinman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies
Mattoo and Cherry
Clin. Microbiol. Rev. 2005;18:326-382.
ABSTRACT | FULL TEXT  

Safety of Vaccinations: Miss America, the Media, and Public Health
Freed et al.
JAMA 1996;276:1869-1872.
ABSTRACT  

Decision Analysis, Public Policy, and Pertussis: Are They Compatible?
Med Decis Making 1987;7:71-73.